Thoratec's LVAD (left ventricular assist devices) "near breakthrough" class, says US committee
This article was originally published in Clinica
Executive Summary
Heart failure patients who are not candidates for a heart transplant should be eligible to receive left ventricular assist (LVADs) devices from Medicare, a government advisory committee voted on March 12.